Innovaccer, a San Francisco, California-based Healthcare SaaS start-up, raised a $150 million Series E round at a $3.2 billion valuation, bringing the total capital raised by the company to over $375 million.
The round was led by Mubadala Capital, with participation from existing investors B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, and new investors Whale Rock Capital Management, Avidity Partners, and Schonfeld Strategic Advisors.
The San Francisco-based company plans to use its new funding to invest in R&D and recruit new hires as it rapidly scales its customer experience, product, and engineering talent.
Company: Innovaccer Inc
Round: Series E
Funding Month: December 2021
Lead Investors: Mubadala Capital
Additional Investors: B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners, and Schonfeld Strategic Advisors
Company Website: https://innovaccer.com/
Software Category: Healthcare data activation platform
About the Company: Founded in 2014, Innovaccer Inc is a leading healthcare data activation platform company focused on delivering more efficient and effective healthcare through the use of pioneering analytics and transparent, clean, and accurate data. Innovaccer has built a software platform that is used by leading healthcare organizations—including Orlando Health, MercyOne, and CommonSpirit Health—that unifies previously siloed data and helps them achieve better care quality at a lower cost. Its products have been deployed across more than 500 locations with over 10,000 providers leveraging it at institutions, governmental organizations, and several corporate enterprises such as Mercy ACO, StratiFi Health, Catalyst Health Network, Osler Health Network, and PHIX HIE. Innovaccer is based in San Francisco with offices around the United States and Asia.